Stay updated on Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial

Sign up to get notified when there's something new on the Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0, replacing the previous version v2.9.7.
    Difference
    0.4%
    Check dated 2024-07-23T14:28:07.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T06:17:47.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T14:01:40.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content related to the study record details of the clinical trial for Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID. The revision reflects the latest information and updates made to the study record.
    Difference
    0.1%
    Check dated 2024-06-27T10:08:30.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the web page.
    Difference
    0.1%
    Check dated 2024-06-26T08:59:27.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The recent change in the web page value from 'Show more Show more Revision: v2.9.0' to 'Show less MedlinePlus Genetics related topics: Adenosine deaminase deficiency MedlinePlus related topics: Genes and Gene Therapy Stem Cells Genetic and Rare Diseases Information Center resources: Severe Combined Immunodeficiency Adenosine Deaminase Deficiency Drug Information available for: Busulfan FDA Drug and Device Resources' represents an update in the content displayed on the page, providing detailed information on genetics, related topics, and resources for Severe Combined Immunodeficiency and Adenosine Deaminase Deficiency.
    Difference
    21%
    Check dated 2024-06-25T08:32:16.000Z thumbnail image

Stay in the know with updates to Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial page.